CASI Pharmaceuticals Inc.

NASDAQ: CASI · Real-Time Price · USD
2.13
-0.04 (-1.84%)
At close: Aug 20, 2025, 9:41 AM

CASI Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13.47M 17.08M 47.11M 38.7M
Short-Term Investments
2.62M 13.69M 4.22M 9.87M
Long-Term Investments
1.72M 1.69M 7.46M 40.13M
Other Long-Term Assets
587K 766K 1.06M 2.18M
Receivables
15.35M 10.14M 12.97M 9.8M
Inventory
5.25M 15.88M 6.14M 1.91M
Other Current Assets
2.89M 2.56M 2.98M n/a
Total Current Assets
39.58M 59.34M 73.42M 61.97M
Property-Plant & Equipment
11.36M 11.63M 13.23M 21.82M
Goodwill & Intangibles
238K 1.84M 1.06M 12.2M
Total Long-Term Assets
13.9M 15.92M 22.81M 76.33M
Total Assets
53.67M 75.27M 96.23M 138.3M
Account Payables
2.72M 4.44M 3.29M 4.79M
Deferred Revenue
2.47M n/a 2.62M 2.83M
Short-Term Debt
18.39M n/a n/a n/a
Other Current Liabilities
10.31M 8.44M 8.04M 519K
Total Current Liabilities
36.45M 16.73M 17M 13.19M
Long-Term Debt
n/a 18.89M n/a n/a
Other Long-Term Liabilities
12.84M 13.87M 11.82M 13.22M
Total Long-Term Liabilities
15.37M 34.38M 12.3M 17.15M
Total Liabilities
51.82M 51.1M 29.3M 30.34M
Total Debt
22.14M 21.24M 1.34M 2.17M
Common Stock
2K 1K 1K 1.4M
Retained Earnings
-700.08M -660.82M -637.16M -605.64M
Comprehensive Income
-1.77M -1.2M -703K 1.95M
Shareholders Equity
1.85M 24.16M 44.57M 84.5M
Total Investments
4.34M 15.37M 11.69M 50M